Adam S. Cheifetz - Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center

基本信息

浏览量：88

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 371 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

CHANGING THERAPY TO ACHIEVE ENDOSCOPIC HEALING IN ASYMPTOMATIC PATIENTS WITH IBD: WHEN IS PERFECT THE ENEMY OF GOOD

H. Systrom,V. Rai,S. Singh,L. Baidoo,A. Cheifetz,S. Devlin,K. Gecse,P. Irving,G. Kaplan,P. Kozuch,T. Ullman,M. Sparrow,G. Melmed,C. Siegel

Inflammatory Bowel Diseasesno. Supplement_1 (2024)

引用0浏览0引用

Factors Associated with Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease

Alexander Abadir, Angela Troia,Hyder Said,Spurthi Tarugu,Benjamin C. Billingsley, Nathan Sairam,Scott B. Minchenberg,Anna H. Owings,Adam M. Parker,Brandon Brousse,Alexander Carlyle, Bobby R. Owens,Pegah Hosseini-Carroll,Michelle Galeas-Pena, Joseph Frasca,Sarah C. Glover,Konstantinos Papamichael,Adam S. Cheifetz

DIGESTIVE DISEASES AND SCIENCESno. 8 (2024): 2796-2803

引用0浏览0WOS引用

When Perfect Is the Enemy of Good: Results of a RAND Appropriateness Panel on Treat to Target in Asymptomatic Inflammatory Bowel Disease

Hannah K Systrom,Victoria Rai,Siddharth Singh,Leonard Baidoo,Adam S Cheifetz,Shane M Devlin,Krisztina B Gecse,Peter M Irving,Gilaad G Kaplan,Patricia L Kozuch,Thomas Ullman,Miles P Sparrow,Gil Y Melmed,Corey A Siegel

The American journal of gastroenterology (2024)

引用0浏览0WOS引用

Risankizumab Concentration but Not IL-22 Levels Are Associated with Clinical and Biochemical Remission in Patients with Crohn's Disease

Xavier Roblin, E. Moschetti,Mathilde Barrau,Adam S. Cheifetz,Konstantinos Papamichael,Stephane Paul

Clinical Gastroenterology and Hepatology (2024)

引用0浏览0WOS引用

Mo1754 CELL-FREE MITOCHONDRIAL DNA IS INCREASED IN THE SERUM OF PATIENTS WITH FIBROSTENOTIC FORM OF CROHN'S DISEASE: POTENTIAL BIOMARKER FOR INTESTINAL FIBROSIS

Maram M. Alenzi,Kristen Crowell,Yuho Ono,Heansika Matta,Pinzhu Huang, Giuseppe Pettinato,Efi Kokkotou,Zhenghui G. Jiang,Adam S. Cheifetz,Laurie B. Grossberg,Yury Popov

Gastroenterologyno. 5 (2024): S-1098

引用0浏览0引用

Sexual Health in Sexual and Gender Minority Patients with Inflammatory Bowel Disease

Andrew Eidelberg,Jordan Axelrad,Victor Chedid,Sarah Ballou,Adam Cheifetz,Loren G. Rabinowitz

Digestive Diseases and Sciencesno. 3 (2024): 1-6

引用0浏览0WOS引用

Mo1858 PROACTIVE COMPARED TO REACTIVE THERAPEUTIC DRUG MONITORING FOR OPTIMIZING VEDOLIZUMAB MAINTENANCE THERAPY IS ASSOCIATED WITH LESS TREATMENT FAILURE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Rachel Porth,Tina Deyhim,Samantha Zullow,Loren Rabinowitz,Laurie B. Grossberg,Adam S. Cheifetz,Konstantinos Papamichail

Gastroenterologyno. 5 (2024): S-1146-S-1147

引用0浏览0引用

Anti-infliximab Antibodies and Low Infliximab Levels Correlate with Drug Discontinuation in Pediatric Inflammatory Bowel Disease

Naamah Zitomersky,Lisa Chi,Enju Liu,Kurtis R. Bray,Konstantinos Papamichael,Adam S. Cheifetz,Scott B. Snapper,Athos Bousvaros,Jocelyn A. Silvester

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITIONno. 2 (2024): 261-271

引用0浏览0WOS引用

What Is the Approach for Loss of Response to Biological Therapy

Konstantinos Papamichael,Adam Cheifetz

Curbside Consultation in IBDpp.103-108, (2024)

引用0浏览0引用

Proactive Therapeutic Drug Monitoring of Ustekinumab is Associated with Increased Drug Persistence in Patients with Inflammatory Bowel Disease

Rachel Porth,Tina Deyhim, Grace Geeganage, Brenden Smith,Samantha Zullow,Loren G. Rabinowitz,Laurie B. Grossberg,Adam S. Cheifetz,Konstantinos Papamichael

American Journal of Gastroenterologyno. 10S (2024)

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn